Fundz

Breast Cancer Ai Company Fathomx Raises Sgd$ 2.24 Million In Pre-Series A Funding

PRIVATESep 01, 2022

Round Type

Pre-Series A

SingaporeBiotechnologyHealth CareArtificial IntelligenceMedical

Description

Singapore-based digital health AI company FathomX, a spin-off company from the National University of Singapore (NUS) and National University Health System (NUHS), recently raised a Pre-series A fund of SGD$ 2.24 million in the lead up to Series A funding.

Quick answer

FathomX raised an undisclosed amount in a Pre-Series A round, dated September 1, 2022. FathomX is based in Singapore.

How much did FathomX raise?
FathomX raised an undisclosed amount in a Pre-Series A round on September 1, 2022.
What does FathomX do?
FathomX, a digital health AI spin-off company from the National University of Singapore and National University Health System, aims to develop a range of AI technologies in the field of breast cancer.
Where is FathomX based and how big is it?
FathomX is based in Singapore.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as FathomX that raised within 45 days of this round, from Fundz verified event records.

  • Optellum raised $14M (Series A) on September 27, 2022.
  • Leuko raised $5M (Series A) on September 23, 2022.
  • Incepto raised $27M (Funding Round) on September 19, 2022.
  • Avenda Health, Inc. raised $10M (Series B) on August 25, 2022.
  • Adastra raised an undisclosed amount on August 22, 2022.
  • Ubie raised $26M (Series C) on August 22, 2022.

Who to call at FathomX, and when

A new round usually means FathomX is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day FathomX raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at FathomX, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at FathomX. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

FathomX

Location

Singapore

About

FathomX, a digital health AI spin-off company from the National University of Singapore and National University Health System, aims to develop a range of AI technologies in the field of breast cancer. The company develops knowledge, capabilities and value through collaborations with research and healthcare institutions, deployment and teleradiology partners as well as picture archiving and communication systems (PACS). For more information, visit www.fathomx.co

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment FathomX raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for FathomX's next move

See what Strategic adds

FathomX raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.